Novartis Shanghai R&D Center To Focus On Diseases Prevalent In China

Novartis will break ground in July 2007 on an integrated biomedical R&D center in Shanghai's Zhangjiang Hi-Tech park as part of a commitment to conduct research in China, the Swiss company announced Nov. 6. Novartis will initially invest $96 mil. to create the Shanghai site